EPO’s CRISPR hearing: day one
Dr Emma Longland, HGF
The European Patent Office (EPO)’s Board of Appeal is currently undertaking oral hearings in a long-running patent dispute
involving the Broad Institute, over the revocation of one of its CRISPR patents.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.